Original Research

Published on 17 Nov 2022

Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors

in Pediatric Oncology

Margot A. Lazow
Christine Fuller
Andrew T. Trout
Joseph R. Stanek
Jaime Reuss
Brian K. Turpin
Sara Szabo
Ralph Salloum

Frontiers in Oncology

doi 10.3389/fonc.2022.996489

1,780 views
4 citations

Original Research

Published on 16 Nov 2022

Case report: A rare case of TBL1XR1-RARB positive acute promyelocytic leukemia in child and review of the literature

in Pediatric Oncology

Mingyan Jiang
Jinrong Li
Jianrong Wu
Yiping Zhu
Ju Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.1028089

2,542 views
3 citations

Original Research

Published on 15 Nov 2022

“Finding my way in a maze while the clock is ticking”: The daily life challenges of adolescents and young adults with an uncertain or poor cancer prognosis

in Pediatric Oncology

Vivian W. G. Burgers
Martin J. van den Bent
Linda Dirven
Roy I. Lalisang
Jacqueline M. Tromp
Annette Compter
Mathilde Kouwenhoven
Monique E. M. M. Bos
Adrianus de Langen
Milou J. P. Reuvers

Frontiers in Oncology

doi 10.3389/fonc.2022.994934

2,763 views
9 citations

Case Report

Published on 10 Nov 2022

Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports

in Pediatric Oncology

Qiang Chen
Yunxuan Zhang
Chenyu Sun
Li Liu
Xiaoyan Luo
Hua Wang
Sili Ni

Frontiers in Oncology

doi 10.3389/fonc.2022.1000099

2,374 views
2 citations

Original Research

Published on 08 Nov 2022

Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases

in Pediatric Oncology

Changfeng Wang
Jiali Sun
Lei Guo
Dan Song
Xin Zhang
Zhuang Liu
Liang Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1014465

1,547 views
6 citations

Original Research

Published on 08 Nov 2022

Associations between exercise capacity, p16INK4a expression and inflammation among adult survivors of childhood cancer

in Pediatric Oncology

Chelsea G. Goodenough
Matthew D. Wogksch
Mondira Kundu
Matthew Lear
Paul G. Thomas
Deo Kumar Srivastava
Zhaoming Wang
Gregory T. Armstrong
Melissa M. Hudson
Leslie L. Robison

Frontiers in Oncology

doi 10.3389/fonc.2022.1014661

2,277 views
4 citations

Original Research

Published on 02 Nov 2022

Back to school – The teachers’ worries and needs having a childhood cancer patient or survivor in their class

in Pediatric Oncology

Maria Otth
Katrin Scheinemann

Frontiers in Oncology

doi 10.3389/fonc.2022.992584

2,123 views
3 citations

Mini Review

Published on 02 Nov 2022

Retinoblastoma: Review and new insights

in Pediatric Oncology

Claudia Carolina Cruz-Gálvez
Juan Carlos Ordaz-Favila
Víctor Manuel Villar-Calvo
Martha Edith Cancino-Marentes
Vanessa Bosch-Canto

Frontiers in Oncology

doi 10.3389/fonc.2022.963780

10,673 views
21 citations

Original Research

Published on 24 Oct 2022

A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy

in Pediatric Oncology

Dristhi Ragoonanan
Saleh Bhar
Gopi Mohan
Fernando Beltramo
Sajad J. Khazal
Caitlin Hurley
Clark Andersen
Steven Margossian
Sattva S. Neelapu
Elizabeth Shpall

Frontiers in Oncology

doi 10.3389/fonc.2022.1022901

4,083 views
1 citation

Case Report

Published on 24 Oct 2022

Case report: First case of undifferentiated embryonal sarcoma of the liver in a child with neurofibromatosis type 1, treated by hepatic chemoperfusion with transcatheter arterial chemoembolization

in Pediatric Oncology

Ksenia Sinichenkova
Ludmila Yasko
Dmitry Akhaladze
Anton Petrushin
Dmitry Konovalov
Ruslan Abasov
Yulia Mareeva
Olga Melekhina
Natalia Usman
Alexander Karachunsky

Frontiers in Oncology

doi 10.3389/fonc.2022.981230

1,337 views
1 citation

Original Research

Published on 21 Oct 2022

RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

in Pediatric Oncology

Lei Lou
Luping Chen
Yaohao Wu
Gang Zhang
Ronglin Qiu
Jianhang Su
Zhuangjie Zhao
Zijie Lu
Minyi Liao
Xiaogeng Deng

Frontiers in Oncology

doi 10.3389/fonc.2022.982110

2,531 views
1 citation

Original Research

Published on 20 Oct 2022

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma

in Pediatric Oncology

Tingting Chen
Chenggong Zeng
Zhuoran Li
Juan Wang
Feifei Sun
Junting Huang
Suying Lu
Jia Zhu
Yizhuo Zhang
Xiaofei Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.1019106

1,743 views
5 citations

Mini Review

Published on 20 Oct 2022

Chromosome instability in neuroblastoma: A pathway to aggressive disease

in Pediatric Oncology

Lucia Paolini
Sajjad Hussain
Paul J. Galardy

Frontiers in Oncology

doi 10.3389/fonc.2022.988972

2,851 views
5 citations

Case Report

Published on 17 Oct 2022

Complete remission of Hodgkin’s lymphoma in a pediatric patient with TTN gene mutation treated with brentuximab vedotin combined chemotherapy without anthracyclines: A case report

in Pediatric Oncology

Ying Li
Ligang Liu
Hao Sun
Nan Li
Shuang Huang
Alexander Olinger
Xiaolin Xu
Xiaoling Wang
Yanlong Duan

Frontiers in Oncology

doi 10.3389/fonc.2022.1006166

1,627 views
2 citations

Original Research

Published on 13 Oct 2022

Compassionate de-escalation of life-sustaining treatments in pediatric oncology: An opportunity for palliative care and intensive care collaboration

in Pediatric Oncology

Andrea Cuviello
Melisa Pasli
Caitlin Hurley
Shalini Bhatia
Doralina L. Anghelescu
Justin N. Baker

Frontiers in Oncology

doi 10.3389/fonc.2022.1017272

2,806 views
1 citation

Original Research

Published on 12 Oct 2022

Multilevel impacts of a pediatric early warning system in resource-limited pediatric oncology hospitals

in Pediatric Oncology

Emily Mirochnick
Dylan E. Graetz
Gia Ferrara
Maria Puerto-Torres
Srinithya R. Gillipelli
Paul Elish
Hilmarie Muniz-Talavera
Alejandra Gonzalez-Ruiz
Miriam Armenta
Camila Barra

Frontiers in Oncology

doi 10.3389/fonc.2022.1018224

2,862 views
9 citations

Navigation group

Articles

Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors

Case report: A rare case of TBL1XR1-RARB positive acute promyelocytic leukemia in child and review of the literature

“Finding my way in a maze while the clock is ticking”: The daily life challenges of adolescents and young adults with an uncertain or poor cancer prognosis

Case report: Deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: Three cases reports

Low-dose sclerotherapy with lauromacrogol in the treatment of infantile hemangiomas: A retrospective analysis of 368 cases

Associations between exercise capacity, p16INK4a expression and inflammation among adult survivors of childhood cancer

Back to school – The teachers’ worries and needs having a childhood cancer patient or survivor in their class

Retinoblastoma: Review and new insights

A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy

Case report: First case of undifferentiated embryonal sarcoma of the liver in a child with neurofibromatosis type 1, treated by hepatic chemoperfusion with transcatheter arterial chemoembolization

RETRACTED: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma

Chromosome instability in neuroblastoma: A pathway to aggressive disease

Complete remission of Hodgkin’s lymphoma in a pediatric patient with TTN gene mutation treated with brentuximab vedotin combined chemotherapy without anthracyclines: A case report

Compassionate de-escalation of life-sustaining treatments in pediatric oncology: An opportunity for palliative care and intensive care collaboration

Multilevel impacts of a pediatric early warning system in resource-limited pediatric oncology hospitals